In 2007, an ambitions team of medical experts founded Medisure medical in the UAE with a goal of improving lives and delivering crucial heart treatment to sufferers across the region. After considerable success, Medisure was transformed again in 2016, when a group of industry leaders and powerful investors who brought more than 15 years of experience marketing medical equipment joined the company. With that extra backing and expertise, Medisure was in a position to expand its goals and expand its portfolio, offering more specialized treatment to more people, changing even more lives throughout the UAE.
Today, as part of Cardiovascular core therapies, we have brought new, innovate and effective solutions in a number of diverse fields, including Neuro Surgery, Spine and Orthopaedic Surgery, Neurology and General Surgery, delivering life-changing approaches to long term suffering. Our vision and drive is focused on improving the condition of chronic disease patients through cutting-edge medical technology, innovative therapies and constant improvement. Our team works tirelessly in partnership with partners throughout the industry, refining proven treatments and new approaches to provide effective treatment that transforms lives and delivers a brighter future for patients across the country.
Our extensive record in the UAE has established us as a leader in our field, bringing a host of new approaches to the country and our patients, including:
- Robotic Surgery
- Surgical Head Mounted Microscope
- Deep Brain Stimulation
- Bioresorbable Coronary stent
- Cardiac Ventricle Assist Device
- Transcatheter Aortic Valve Replacement
- Transcatheter Mitral Valve Repair
- ECG Mobile Cardiac Telemetry
- Medical 3D Printing
Our journey does not end here though, our commitment to identify, evaluate, refine and introduce new treatments to the UAE for the first time in order to ease suffering and change lives remains as strong as ever. We will continue to work with our partners and healthcare providers to deliver effective treatment.
CEO Message
"To deliver innovative therapeutic and diagnostic solutions that protect human and cure patients"
As medical technology advances rapidly, established ideas of treatment are constantly being challenged, and we are right at the forefront of that, leading the adoption of new thinking and innovation. Through effective relationships with industry partners, healthcare providers and physicians across the UAE, we identify, refine and deliver new treatments, new technological approaches, and new ideas to ease the suffering of patients with chronic disease. Our goal is to transform lives through medical innovation, today and into the future.
- Building a real partnership with healthcare providers and phy sicians, to introduce new solutions for patients.
- Continuous development to our team that will satisfy our cli ents and patients.
- Helping healthcare providers to adopt new solutions by con ducting workshop and required trainings.
- To be ethical, responsible and knowledgeable.
- To put our customers & patients first.
- To work with integrity and honesty.
A healthy heart is essential to good health. That's why at Abbott throws hearts into advancing treatments for people with cardiovascular disease. Abbott breakthrough medical technologies — many of which are minimally invasive — help restore people's health so they can get back to living their best lives, faster. Abbott focuses on innovative technologies that can improve the way doctors treat people with vascular diseases, heart arrhythmias (irregular heartbeats) and diseases of the heart’s valves.
Cardiodiagnostics is a medical technology company specialized in data analytics and bringing cutting-edge mobile cardiac telemetry technology to the international market established in USA with global R&D offices, the company develops proprietary technologies to monitor patients' hearts wirelessly. The team of experts is working together to meet the market needs and solve existing problems in the cardiac care industry through research-based pioneering technologies.. CardioDiagnostics is focused on creating Remote Cardiac Monitoring technologies in the aim of treating patients with cardiac problems. Patients may continue normal day-to-day lifestyle, while CardioDiagnostics makes sure that physicians receive vital cardiac information needed to make a proper diagnosis
CNSystems’ core technologies are made for painless and reliable cardiovascular diagnosis, monitoring and therapy control in order to improve patient care and medical outcome. The company has achieved technological leadership in developing a noninvasive, easy-to-use and accurate diagnosis and patient monitoring systems for better and easier insights into the cardiovascular system and its control mechanism located in the brain.
AtCor develops and markets medical technologies that measure patient risk for hypertension, cardiovascular disease (CVD), and other related vascular disorders. Atcor helps clinicians with early detection of target organ damage and management of cardiovascular and renal disease.AtCor technology is featured in over 1,400 peer-reviewed publications in leading medical journals.
AliveCor delivers intelligent, highly-personalized information about the heart to clinicians and patients while first-generation monitoring systems are challenging to navigate and difficult to monetize, KardiaPro presents data in a simple, intuitive format.
A healthy heart is essential to good health. That's why at Abbott throws hearts into advancing treatments for people with cardiovascular disease. Abbott breakthrough medical technologies — many of which are minimally invasive — help restore people's health so they can get back to living their best lives, faster. Abbott focuses on innovative technologies that can improve the way doctors treat people with vascular diseases, heart arrhythmias (irregular heartbeats) and diseases of the heart’s valves.
Asahi Intecc develops, produces and sells various medical devices required for catheter treatment. Treatment areas where these devices are used is not limited to cardiovascular system areas but also extends to areas of the peripheral vascular system, abdominal vascular system, cerebrovascular system and other areas. With ASAHI outstanding development capabilities and production technologies in the medical device field, they hold a high share not just in the Japanese market but also globally.
Cardiodiagnostics is a medical technology company specialized in data analytics and bringing cutting-edge mobile cardiac telemetry technology to the international market established in USA with global R&D offices, the company develops proprietary technologies to monitor patients' hearts wirelessly. The team of experts is working together to meet the market needs and solve existing problems in the cardiac care industry through research-based pioneering technologies.. CardioDiagnostics is focused on creating Remote Cardiac Monitoring technologies in the aim of treating patients with cardiac problems. Patients may continue normal day-to-day lifestyle, while CardioDiagnostics makes sure that physicians receive vital cardiac information needed to make a proper diagnosis
Istem Medical is an establishment that takes place in the sales and marketing area of the medical sector since 1995. Today Istem Medikal has become the leader of the sector which has also started to export aiming to get first place in the international arena.
Istem Medicals vision is to accelerate the development of the health sector doing the best that possible.ISTEM MEDICAL that has EN ISO 9001:2015 and EN ISO: 13485:2016 quality certificates aims to be the pioneer in the sector.
Stimwave has the first FDA cleared Freedom System™ for Spinal Cord Stimulation, Dorsal Root Ganglion Stimulation, and Peripheral Nerve Stimulation. The Stimwave Stimulator System, with just a single device implanted through a needle, provides a non-surgical therapy option for chronic pain. This system utilizes the world’s smallest, wireless, microsize neurostimulator and leverages patented advancements in microtechnology. The Stimwave platform is revolutionizing the industry
Peters Surgical is a French company which develops, manufactures and sells medical devices for the surgeon. Péters Surgical is acting on the market of sterilized single use medical devices for operating room. It is specialized in sutures, devices for temporary and permanent vascular occlusion, wall reinforcement, surgical glue, single use instruments for laparoscopic surgery, drains, etc. Peters Surgical company is the unique French firm manufacturing and selling surgical sutures and is the European leader for haemostatic clips.
LSI SOLUTIONS was founded in 1986 by Jude S. Sauer, M.D., with a mission to lead the world in medical product innovation and passion to focus on patient outcomes. What once started with a focus on laser tissue welding has evolved into a world-renowned company dedicated to advancing minimally invasive therapeutics through research, development, manufacturing, and marketing of proprietary products.
EMCOOL is an Austrian company founded in 2005, with special focus on developing Target Temperature Management solution to address the clinical needs of hypothermia and normothermia. EMCOOL produces the Flex-Pad with patented Hypocarbon technology that contributes to fast and sustainable temperature reduction. The Flex-Pad is safe, simple and cost effective solution when it comes to temperature management.
Copyright © 2021.
Medisure Medical. All Rights Reserved